UBS Global Life Sciences Conference, Day 2: Cepheid, Complete Genomics, ProteinSimple, Luminex, Response Genetics | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The second day of the UBS Global Life Sciences Conference in New York featured several life science tools and molecular diagnostics companies making their pitches to the investor community.

Below are capsules from their presentations and breakout sessions.


Cepheid CFO Andrew Miller provided investors with an update on the firm's ambitious plans for rolling out new molecular tests over the next five years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.